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 INTRODUCTION 
 
    Urinary cytology has an increasingly prominent role in the 
multidisciplinary diagnostic approach to bladder cancer. It is used as a valuable 
adjunct to cystoscopy and biopsy for diagnosis and follow up of patients with 
bladder cancer. 
Bladder cancer accounts for 7% of all cancers in male and 2% of all 
cancers in female. In the year 2002, in Chennai Bladder cancer accounted for 
2.28 % of all cancers in male and 0.78 % of all cancers in female29. 
Cytological examination of voided urine is a non-invasive screening test 
for bladder tumors, which can be carried out in remote areas of the country. By 
cytology one can even classify type and grade malignancy.   
In 1945 Papaniculoau and Marshall recommended cytological 
examination of urinary sediment for diagnosis and follow up of patients with 
urological malignancies.    
The prognostic value of conventional cytology to monitor patients with 
superficial bladder carcinoma is well established. While cystoscopy and biopsy 
are optimum for diagnosis of visible disease, the entire bladder mucosa can be 
sampled by cytology, enabling detection of occult urothelial abnormalities.    
Traditionally cytological examinations have been used to detect in situ 
and early invasive bladder cancer in high-risk population and in conjunction 
with cystoscopy and biopsy to diagnose new or recurrent bladder tumor.  
 Cytology also has been used to identify persistent tumor after transurethral 
resection.  
Cystoscopy remains the standard for the diagnosis and surveillance of 
bladder tumors, allowing the lesions to be mapped and sampled.  However, 
cystoscopy cannot explore the whole bladder urothelium, and cannot diagnose 
all carcinoma in situ cases or lesions of upper urinary tract.  Thus, it must be 
combined with urinary cytology, particularly in search for tumor cells from 
high-grade lesions, wherever their location in the urinary tract. 
Urine cytology can detect bladder tumor before it can be detected 
cystoscopically. Urine cytology is still indispensable in the management of 
patients with transitional cell carcinoma. It remains as a gold standard for 
bladder cancer screening. 
 
 
 
 
 
                                                                          
 
 
 
 
 
 
 
 
 
  
 
 
 
AIMS 
 
1. To study the value of urinary cytology in the diagnosis of bladder 
cancer. 
2. To correlate urine cytology with biopsies of the bladder neoplasm. 
3. To analyze the reason for false positive and false negative cytological 
results. 
4. To correlate urine cytology findings with cystoscopic findings. 
 
 REVIEW OF LITERATURE 
 
Cancer bladder was first noted in man in aniline industry in 1895.  
Cancer bladder is three times more common in men than in women and twice 
as common among whites as among blacks. The average patient is 65 to 70 
years old and most patients are older than 50 years of age.                                                          
The bladder temporarily stores concentrated toxic products of renal 
excretion and is vulnerable to environmental carcinogens. Most important risk 
factors for the development of transitional cell carcinoma are aniline dyes 
containing arylamines, e.g.benzidine, beeta naphthylamine. High-risk 
occupations include chemical, dye, textile, rubber, and plastic workers as well 
as painters and hairdressers. Cigarette smoking is a risk factor for bladder 
cancer. Certain drugs [eg.chemotherapeutic agents, phenacetin and opiates] are 
associated with the development of bladder cancer. 
Schistosoma haematobium infection is a risk factor for sqamous cell 
carcinoma. Previous exposure of the bladder to radiation increases the risk of 
urothelial carcinoma. Many genetic alterations are observed in urothelial cell 
carcinoma, comman are chromosome 9 monosomy or deletions of 9p and 9q, 
deletions of 17p, 13q, 11p and 14q. The pathway, which is initiated by deletions 
of tumor suppressor genes on 9p and 9q leads to superficial papillary tumors, a 
few of which may then acquire P53 mutations and progress to invasion. The 
second pathway, which is initiated by P53 mutations leads to carcinoma in situ 
and with loss of chromosome 9, progresses to invasion. 
 The urocarcinogens, by injuring the coding units of the urothelial cells, 
render them defective, leading to hyperplasia and neoplasia, with the action of  
promoters. Neoplastic urothelial cells that penetrate the submucosa and/or 
muscularis are autonomous27. 
TUMORS OF THE URINARY BLADDER17  
Benign epithelial tumors 
Typical papilloma  
Inverted papilloma 
Villous adenoma 
Mucinous cystadenoma of the urachus 
Squamous papilloma 
 
Malignant epithelial tumors 
Transitional cell carcinoma  
Papillary 
(1) Non-invasive 
(2) Invasive 
 
 
 
Non-papillary 
(1) Transitional cell carcinoma in-situ 
(2) Invasive transitional cell carcinoma 
      
Squamous cell carcinoma. 
Adenocarcinoma 
Carcinomas of more than one histologic type 
Mesenchymal tumors 
Benign 
Malignanat  
      (1) Leiomyosarcoma 
     (2) Rhabdomyosarcoma 
     (3) Others 
Mixed tumors 
Adenofibromas and adenosarcomas 
Carcinosarcoma 
Hematopoietic neoplasms 
Lymphoma 
Leukemia 
Plasmacytoma 
 
 
Miscellaneous primary tumors 
Paraganglioma 
Carcinoid 
Malignant melanoma 
Dermoid cyst 
Yolk sac tumor 
Metastatic tumors 
URINE CYTOLOGY  
 Tumor cells in the urine were identified first by Sanders in 1864 and 
Dickson in 1869. In 1892, Ferguson suggested that microscopic examination of 
the urine sediment, except for cystoscopy was the best method for diagnosing 
tumors of the bladder. Rovising in 1895 reported malignant cells in the urine 
sediment of 3 out of 7 patients with kidney tumors.   
 However, in 1928 Zemansky correlated urinary findings with 
subsequent tissue examination in 46 cases of suspected tumors and called the 
 urine unfit for cytologic study. Interest in cytologic diagnosis waned until the 
studies by Papaniculaou and Marshell in 1945, supplemented by Papniculaou a 
year later demonstrated the usefulness of smear technique in diagnosing 
cancers of urinary organs. Because of the normal desquamation from epithelial 
surfaces, which increases in the presence of neoplasia, they considered the 
urine sediment most suitable for the identification of cells with malignant 
characteristics32. 
           Since Papanicolaou and Marshall demonstrated in 1945 that a bladder 
tumor undergoes exfoliation, which renders possible its recognition by 
detection of abnormal cells in the urine, cytology has become an important 
adjuvant for the diagnosis and follow up of patients with cancer.  In 1964 
Umiker reviewed the literature on the value of urinary cytology and found 
positive results ranging from 26.1 to 100% with an average of 71.6%. In 1972, 
Harris and associates used the principle of gastric washing for cytology, which 
was reported previously by Villarded, and performed bladder irrigation, his 
yield improved by 30% over urinary cytology.  In 1970, Esposti and associates 
emphasized the importance of the pathological grading of the tumor in 
influencing the cytological results43. 
          Tumors of the urinary tract are relatively inaccessible to direct biopsy 
and the tumors are often multifocal. Since the entire mucosal surface is bathed 
in urine, in theory urine is the perfect specimen to examine for evidence of 
tumor in the urinary tract. 
Urinary cytology is useful in the detection of  
 1. Urothelial carcinoma in its preclinical phase.  
2. Carcinoma in situ.   
3. Malignant change in papilloma.   
4. Follow up of patients after treatment to detect any residual or recurrent 
tumors. 
    Cytologic examination of the sediment of voided urine is the only 
noninvasive method of detection, diagnosis and follow up of tumors of the 
bladder and other anatomic components of the lower urinary tract. Urine 
cytology is a cost effective method.                                                                                              
    Urine cytology remains gold standard for bladder cancer screening.  It is the 
test against which all others are compared when evaluating potential bladder 
tumor markers.  It has excellent specificity with few false positive cases.  It 
detects high grade malignant cells even before a cystoscopically 
distinguishable gross lesion is present11. Urine cytology is capable of detecting 
malignant non-exophytic tumor types that ultrasound cannot detect34.  
     The study conducted by M. N. EL-Bolkainy30 1980 showed that the 
cytology is highly effective in the primary diagnosis of high grade transitional 
cell carcinoma with a positive rate of 93-94.7%. 
     The study conducted by Leopold G. Koss et al24 1985 also showed the 
cytology of voided urine is highly reliable in the diagnosis of high grade 
tumors with a sensitivity of 94.2%.  In primary flat carcinoma in situ the 
sensitivity was 100%. 
      Deep stage bladder carcinoma exfoliate more cells of a mixed transitional  
and epidermoid type cells. Superficial stage bladder carcinoma is 
predominantly associated with a pure population of transitional cell carcinoma 
cells. 
      Patients with low-grade non-invasive tumors can be followed up 
cytologically. Patients with negative cytological findings have a very low risk 
of recurrence while high-grade cytological abnormalities predict an aggressive 
tumor course. 
      Niels Harving et al33 1988 in their study, concluded that urinary cytology is 
also better indicator of the presence of concomitant urothelial atypia than 
preselected mucosal biopsies. 
      Post operative (radical operation) examination of urine for malignant cells 
should be made out to monitor the development of new tumors in the kidney  
ureter or occasionally in the intestine itself.  
     Clinical history is imperative for the elimination of misdiagnosis. Pertinent 
information includes the method of specimen collection, the presence of calculi 
and past therapies. To use urine cytology most effectively it is important first to 
understand its advantages and limitations. 
Advantages of voided urine cytology. 
1. Simple, can be easily collected. 
2. Repeated if necessary, with little or no inconvenience for the patient.                                    
3. Inexpensive.                                                                                                                             
4. Non invasive. 
 5. Can be done even in remote areas of the country. 
6. Detects high grade malignancy before cystoscopy can detect. 
7. Samples of urine may contain representative cells from the entire urinary 
tract. So that the entire system can be surveyed. 
Disadvantages of voided urine cytology            
1. Low cellularity. 
2. Contamination from female genital tract. 
3. May contain degenerated cells or reactive transitional cells which may 
give false positive results. 
4. Not localizes the tumor. 
     An important diagnostic principle is that the higher the grade of the tumor, 
the more accurate the diagnosis.   There are several reasons for diagnostic 
inaccuracy. Urine is an inhospitable environment for cells. So degenerative 
changes that make diagnosis difficult are common.  
    False positive results can occur due to mistaking of  atypical cellular changes 
as malignant. Common causes of cellular atypia are cystitis, senile prostate, 
calculi, chemotherapy and radiotherapy effects, and polyoma virus infection.  
     False positive diagnosis of bladder cancer may lead to radical therapy, so a 
positive urine cytologic diagnosis should always be confirmed histologically 
before definitive therapy is instituted12,37. Most patients with false positive 
cytological findings may develop a tumor in subsequent years and therefore 
need repeated examinations of urine for malignant cells. 
     False negative diagnosis may be of more clinical consequence. Cytologic 
 diagnosis of papilloma and well differentiated transitional cell carcinoma can 
be difficult or impossible because the cells are nearly normal appearing. False 
negative diagnosis may be due to low cellularity, poor preservation or 
obscuring of malignant cells by inflammatory cells. 
Suboptimal Specimen 
According to Sheldon Bastacky et al41 1999, urinary specimen is considered 
suboptimal, if the specimen had one or more of the following deficiencies  
1. Less than 15 intermediate or basal urothelial cells. 
2. Obscuring of malignant cells by red blood cells or inflammatory cells.  
3. Poor cellular preservation. 
Apparently false positive (false false positive cytology) 
      Apparently, false positive cytologic results occur when a lesion is actually 
present but is not confirmed histolologically i.e. histological false negative37. It 
can occur in urine cytology because, 
1. Cytologic examination can detect early lesion some times long before they 
are cystoscopically visible for biopsy2,6,11,14,32. 
2. Sample of urine may contain representative cells from the entire urinary 
tract. 
3. Some epithelial lesions particularly carcinoma in situ tend to slough due to 
poor cellular cohesion, resulting in exfoliation of abundant tumor cells in the 
urine and non diagnostic tissue biopsy. 
      Following newer diagnostic techniques have been studied to increase 
 diagnostic efficacy.  
 Flow cytometry16,39. 
 Image analysis1.  
 Immunology e.g.-blood group isoantigens and monoclonal antibodies to 
a variety of tumor associated antigens3,15,16,40,46. 
 Immune histochemical analysis of p53 over expression21. 
 Nuclear matrix protein 22 (NMP22) assay3,15,40,46. 
 The aura Tek FDP assay (Fibrin/Fibrinogen Degradation products)3,40. 
 Measuring telomerase activity3,40. 
 Detecting hyaluronic acid/ Hyaluronidase levels11. 
 BASIC SPECIMEN 
       There are three basic types of exfoliated urinary tract specimens:  
          (1) Voided urine  
          (2) Catheterized urine, and  
          (3) Brushing/washing specimens.  
     "Clean catch" voided urine is recommended for screening purposes. 
However, in cases in which there is a high clinical suspicion for bladder 
malignancy, bladder washing may be the method of choice.  
      Specimens should be processed immediately or refrigerated and processed 
as soon as possible. If a delay is anticipated, immediate fixation with 50% 
ethanol may preserve the specimen for several days16,30,51.  
     A solution of 25% ethanol [equal volume of 50% ethanol and urine.] is 
widely used. This percentage is recommended in order to lessen the shrinkage 
and hardening effects of more concentrated solution52. 
     All urine cytology specimens are sufficiently dilute as to require some form 
of cell concentration.  Initially, cytologic findings were assesed on smears 
made from the sediment of centrifuged specimen.  Subsequently developed 
methods include thin membrane filtration, cytocentrifugation and most recently 
mono layer technique11. 
     Urinary samples can be processed by several techniques including direct 
smears, membrane filters and cytocentrifugation. All have certain advantages 
and  disadvantages. In general direct smears are easiest to prepare but suffer 
 from high cell loss and suboptimal display of cellular details. Membrane filters 
produce the best cytologic details, but are difficult to prepare51. 
     Cytyc thinprep liquid based cytology and cytocentrifugation are appropriate 
methods for cytology based molecular studies but cytocentrifugation remains 
the quality standard for current treatment of urinary samples because of its 
lower cost9. 
 Processing techniques for urinary samples25 
Processing 
technique 
Features 
Direct smear from 
centrifuged specimen 
Easy method, valuable for cytobrush;but shows scant 
cellularity, degeneration and fragmentation of cells 
Cytospin Good cellularity and preservation of cells;but produces 
cell clustering suggesting a low-grade papillary tumor, 
non-cellular contents may obscure the cells, excessive 
spinning can produce hyperchromasia. 
Thin prep Good cellularity;but expensive, loss of cytoplasmic border 
and nuclear details 
Cellulosic (Millipore) 
filters 
Good cellularity, excellent cytomorphology;but expensive 
requires fresh samples and experience 
Parafin cell block Valuable in cytobrush samples. Shows excellent tissue 
architecture;but not recommended for routine urine 
samples 
 
     Papanicolaou stain is usually preferred.  Since fine nuclear detail is often 
crucial to proper diagnosis.  
 
 
 Voided Urine  
     Normal voided urine usually contains only a few cells.  Normal urine 
 contains approximately 10 cells/ml51. Voided urine also contains significant 
amount of skin and vaginal contamination particularly in female. Increased 
cellularity may be seen with instrumentation, stones or neoplasms. 
    The transitional cells in urine have a some what trapezoidal (truncated 
pyramid or trapezium) shape. The transitional cells in a voided urine specimen 
are generally relatively uniform. However, the cells can vary from parabasal to 
relatively large. The nuclei are round to oval with smooth nuclear membranes. 
The chromatin is delicate or condensed. Small nucleoli may be seen. There is 
usually a moderate amount of cytoplasm37.  
     Urine cytology should be performed on freshly voided urine. A mid 
morning sample is the most useful. Fractionated cytology did not improve the 
diagnostic accuracy of urinary cytology and that any part of voided stream is 
adequate for cytological purposes22.  Samples should be collected in a clean 
container and sent to the laboratory immediately. If the specimen has to be 
transported or kept overnight alcohol should be added to preserve the cells  
     Cell loss from slides can be minimized by using adhesive fluids. The 
paraffin blocks of sediments are useful in identification of papillary tumor 
fragments.   
     The optimum number of voided urine samples to submit is three. Of the 
neoplasms that can be diagnosed with voided urine cytology, about 80% will 
be on the first specimen, 15% on the second, and the rest on the third24.  
         Degenerative changes, are common in voided urine specimens. Factors 
 causing degeneration include high acidity and variable osmolality of the urine.     
Degeneration of urothelial cells begin prior to exfoliation and continuous while 
the cells are in contact with urine prior to and after voiding. 
      Specimen should not be submitted from first morning voiding, 24 hours 
collection or drainage bags as prolonged exposure of urothelial cells to urine 
causes degenerative changes.  
Catheterized urine 
     Simple catheterization increases the cellularity over voided urine specimens, 
and the specimen may be somewhat better preserved. However, it makes the 
diagnosis of low-grade lesions more difficult because pseudo papillary clusters 
may be present, and lesions in the urethra may be missed. 
Bladder wash 
     Bladder wash specimens are diagnostically superior to voided urine 
specimens.    The specimens are better preserved, more cellular and there is less 
contamination of the background than voided urine specimen. It is important 
that the urologist submit both the saline wash and the urine present in the 
bladder at cystoscopy ("cysto urine"). Cysto urine does pick up a significant 
number of additional cases of cancer.  
     A freshly voided urine specimen should be submitted to detect lesions in the 
urethra. Although bladder washing is superior to voided urine in diagnosis, it is 
inconvenient, uncomfortable, relatively expensive, and has a risk of infection. 
Advantages and Disadvantages of Voided Urine and Bladder Washing 
 Specimen. 11,16,32,43,45,47,48,49,52 
 
Advantages          Disadvantages       
 
Voided urine  
 
  Easy to obtain specimen                          Degeneration  
 Good sensitivity for high- grade tumor     Few cells, particularly in lowgrade tumor     
  Sample entire tract Contamination, especially from                     
female genital tract  
Bladder washing   
      Excellent preservation                          Inconvenient, uncomfortable, expensive 
     High sensitivity, including                    
low-grade tumors                                        
Possible risk of infection, spread of  tumor 
     Almost no contamination                    Limited sample[ie, urethra, upper                  
urinary tract not sampled] 
  
CELLS 
     Urothelium is composed of superficial layer of large cells which cover 
several layers of uniform smaller cells like an umbrella, hence named umbrella 
cells. Superficial cells have abundant cytoplasm and typical concave and 
convex surfaces with multiple nucleoli. They have a rigid surface membrane 
which does not round up in fluid environment. So that these elements are 
readily identified in urinary samples. They can produce and secrete small 
amount of mucin. Reactive superficial cell may look like a high grade 
neoplastic cell but truly malignant cells rarely if ever differentiate towards 
superficial cells. So these cells should not be misinterpreted as neoplastic cells 
and no cell with a N; C ratio (Nuclear; Cytoplasmic) of 1; 2 or less should be 
considered malignant. 
  
 
Normal voided urine sediment smear showing subsuperficial 
transitional cells. Pap stain 400X. 
 
 
 
Normal urine sediment smear showing superficial cells and sub 
superficial small uniform cells. Papstain 400X. 
 
      Sub superficial transitional cells lie beneath the superficial cell layer. They 
are smaller, uniform, normally filled with glycogen which washes out during 
processing leaving a cleared cytoplasm, surrounding an ovoid nucleus. These 
cells are usually arranged in 3 to 4 cell thick layers but probably not exceeding 
6. They are inactive, replicate every 200 to 500 days. These cells tend to cluster 
in a urinary specimen. Instrumentation can produce papillary aggregates in 
urine but these aggregates are having smooth borders and cells are uniform.  
Papillary configuration perse is an unreliable feature of neoplasia. Reactive sub 
superficial transitional cells develop cytoplasimic vacuolation, nuclear 
enlargement and nucleoli become prominent.Most neoplastic cells tend to 
differentiate toward subsuperficial urothelial cells.It is these elements to which 
comparison of nuclear characteristics between neoplasia and  normal are 
made51. 
     Cytoplasmic vacuolization and prominent nucleoli can be seen in either  
reactive transitional cells or in high grade transitional cell carcinoma, but their 
presence excludes low grade transitional cell carcinoma. 
  
 
 
 
 
 
 
 
Normal urine sediment smear showing superficial cell with double 
nuclei Pap stain 400X. 
 
  
Degenerated Transitional Cells 
 
     Degeneration (caused by inflammation, stones, trauma, etc) can result in 
bizarre transitional cells with darkly condensed coarse or pyknotic chromatin 
Although such changes can resemble cancer, the chromatin of these benign 
cells is usually smudged or degenerated. In contrast, the chromatin granules of 
cancerous cells are characteristically crisp and well preserved. Margination of 
the chromatin, with central clearing, is also frequent in degenerated transitional 
cells. Degenerated nuclei may further undergo karyolysis and karyorrhexis and 
become washed out or broken up. The cytoplasm may disintegrate and be 
merely a tag attached to the nucleus (comet cell) or absent together37. 
Significance of Papillary Clusters. 
     Instrumentation, catheterization or even simple manipulation of the bladder 
produces papillary aggregates, that mimic tissue fragments detached from low 
grade papillary tumors.  
      The papillae from transitional cell carcinoma tend to be disorganized and 
crowded, with irregular borders and mild nuclear atypia, while post 
instrumentation pseudo-papillae tend to be cohesive, ball-shaped, or papillary 
clusters with smooth borders outlined by a densely staining cytoplasmic collar. 
However, when papillary clusters are shed in  urine in low grade transitional 
cell carcinoma, they may be mistaken for artifacts induced by  
instrumentation45.         
  
 
 
Normal urine sediment smear showing squamous cell and transitional 
cells. H&E stain 400X. 
 
 
 
 
 
 
Normal urine sediment smear showing squamous cell and 
transitional cells. H&E stain 400X. 
 
 
 
 
      Uniform central nuclei, smooth nuclear membranes, fine even chromatin, 
low N/C ratios, cytoplasmic vacuoles, and general lack of crowding favor a 
benign diagnosis16.  
Squamous Cells and Squamous Metaplasia 
     Squamous cells are a common finding in urine specimens. Source of 
squamous cells are contamination of urine by squamous cells from urethral 
meatus, female genital tract, cells from trigone, metaplastic squamous cells. 
   Squamous cells are larger than typical deep transitional cells or about the size 
of umbrella cells, while the squamous nuclei are smaller and may be pyknotic. 
Thus, the N/C ratio in a squamous cell is lower than in a transitional cell. The 
cytoplasm of squamous cells is thin compared with the denser cytoplasm 
typical of transitional cells. Squamous metaplasia occurs in chronic 
inflammation or irritation (stones, indwelling catheter). The metaplastic cells 
are usually mature, intermediate, or superficial squamous cells.  Squamous 
metaplasia should be diagnosed only after exclusion of contamination, thus it 
requires a catheterized specimen. 
Columnar cells 
     Columnar cells generally account for less than 5% of all cells in a urinary 
specimen.  They commonly appear after prostatic surgery or instrumentation25.  
Red blood cells and inflammatory cells 
     Normally the urine is virtually free of inflammatory cells and RBCs. 
Significant numbers indicate disease or trauma and when abundant may 
 obscure the presence of tumor cells. Hematuria results from any disease or 
trauma to the Kidney and/or urinary tract and is seen with calculi, neoplasm, 
infections. 
     Eight Red Blood Cells per high power field during urine analysis represents 
abnormal microscopic hematuria21. 
Other cells that may be seen in urine are 
1. Renal tubular cells are seen in kidney disease 
2. Prostatic cells are seen after prostatic massage 
3. Seminal vesicle cells are seen rarely 
4. Endometrial cells are seen mainly in case  of contamination 
5. Lymphocytes are seen in case of cystitis or malignant lymphoma 
6. Plasma cells are seen in case of chronic inflammation or multiple 
myeloma 
7. Histiocytes are seen in case of chronic inflammation, radiation or BCG 
therapy 
8. Multinucleated giant cells may be umbrella cells or they can be seen 
with radiation, BCG therapy or viral infection 
9. Eosinophils are seen in case of urinary tract infection, bladder injury or 
sometimes with bladder cancer 
Miscellaneous  
1. Corpora amylacea of prostatic origin. 
2. Globular or Hyaline, inclusion bodies commonly seen in urinary tract 
cells.  They are associated with degeneration. 
3. Sperm, crystals, casts & various organisms can all be seen in urinary 
 specimen. 
Cellular Reaction to Therapeutic Agents 
1.Cyclophosphamide is alkylating agent given systemically and metabolized to 
active form.  The active form is concentrated in urine and remains in contact 
with urothelial cells for relatively prolonged periods until voided. 
Cyclophosphamide causes cellular atypia that can closely mimic cancer. The 
presence of multinucleated cells with signs of nuclear degeneration 
(karyorrhexis, lysis, and nuclear vacuolization) suggests chemotherapy effect. 
2. Mitomycin C and Thiotepa are topically applied alkylated agents 
administrated in their active form for prevention or treatment of bladder 
neoplasm.  The drugs remain in contact with urothelium for limited periods 
prior to voiding.  Their cytologic manifestations are confined almost 
exclusively to superficial cells, where they cause enlargement of both 
cytoplasm and nuclei resulting in characteristic but bizarre cells. Nuclei are 
usually not hyperchromatic but those that are usually have smudgy appearing 
chromatin. Multiple small nucleoli are common. The cytoplasm is degenerated, 
vacuolated and frayed. 
3. Bacillus Calmette-Guérin [BCG] vaccine is an increasingly common 
therapeutic agent for bladder cancer that is particularly effective in treating 
carcinoma in situ.  BCG therapy can also cause epithelial atypia, including 
slight nuclear  hyperchromasia with cytoplasmic basophilia23. In contrast with 
cancer, the N/C ratio is preserved and the nuclear membranes are smooth. 
Significant nuclear pleomorphism, prominent nucleoli, or cytomegaly are not 
 seen in the transitional cells. 
Radiation 
     Radiation can cause certain cytologic changes, especially multinucleation, 
cytoplasmic vacuolization and nuclear pyknosis.  Bizarre nuclear abnormalities 
can occur51. 
     It is not possible to distinguish with any degree of certainity malignant from 
non-malignant irradiated urothelial cells in urine. History of previous 
irradiation should be given to the cytologist.If numerous bizarre cells appear 
long after radiation, or if there has been an interim period when cytologic 
appearances were normal, then recurrence is strongly suggested36. 
 
BLADDER CANCER 
    Transitional cell carcinoma or urothelial carcinoma accounts for 90% of all 
primary tumors of bladder. 
    Most bladder cancers appear as a focal or multifocal expression of 
widespread abnormality of urothelium, progression of which leads to 
multicentricity in space and recurrence in time.  
 Clinical Presentation 
     Eighty percent of the patients with bladder carcinoma present with gross or 
microscopic, painless and intermittent hematuria. Twenty percent of patients 
will complain of vesical irritative symptoms including urinary frequency and 
urgency. It is important to consider CIS [Carcinoma In Situ.] in any patient 
 with a history of irritative voiding symptoms. Patients with invasive bladder 
cancer may have abdominal tenderness or bladder mass or induration. 
Biologic Pathways  
     Two distinct pathways are suggested in urothelial neoplasia. A lowgrade 
pathway hypothesized in approximately 70% the of cases.  It is characterized 
by progression from hyperplasia/dysplasia to papilloma to low grade 
transitional cell carcinoma. The lesions have bland cytology and normal blood 
group isoantigens and are predominantly diploid. Recurrences are frequent and 
multiple, but only minority of the cases (10 to 15%) progress to muscle 
invasion. 
     In the high grade pathway most invasive lesions arise without a history of 
papillary neoplasms. They progress directly from flat lesions of severe 
dysplasia/carcinoma in situ to invasive high grade transitional cell carcinoma 
and are associated with mortality.  Such lesions have pleomorphic cytology, 
manifest high mitotic rates, lack normal blood group isoantigens, and are 
usually aneuploid11,50. 
     The flat carcinoma in situ may precede invasive carcinoma by months or 
years. A primary goal of urine cytology is to recognize these early flat lesions 
before they invade, as well as to detect the 10% of papillary lesions that are 
destined to invade11. 
Cytologic classification of urothelial malignancy. 
  The lesion acts like it looks51. 
 Cellular features of urothelial neoplasia50,51 
 Low grade High grade 
Cells   
Arrangements   Papillary and loose 
clusters      
Isolated and loose 
clusters 
Size Increased, uniform Increased, pleomorphic 
Number Often numerous Variable 
Cytoplasm Homogeneous Variable May have 
vacuoles 
Nuclear Cytoplasmic 
ratio 
Increased Increased 
 Low grade High grade 
Nuclei    
Position  Extremely eccentric Eccentric 
Size Enlarged Variable 
Morphology Variable within aggregates Variable 
Borders Irregular Irregular 
Chromatin Fine, even coarse, uneven 
Nucleoli Small/Absent                        Variable 
 
General Principles of Cytologic Diagnosis 
     Higher the grade and the more extensive the tumor, greater the ability to 
make a cytologic diagnosis. Cells shed from transitional cell carcinoma in situ 
have a similar cytomorphology as high-grade invasive lesion. One cannot 
reliably determine whether a lesion is in situ or invasive cytologically. 
Differential diagnosis. 
     Differential Diagnosis includes atypia due to catheterization, cystitis, stones, 
radiation and chemotherapy. 
 Differentiating features of reactive cell, low grade and high grade                    
TCC 20,44,50,51 
Feature Reactive Low grade TCC High grade TCC 
Groups Pseudopapillae Pappillae, loose or crowded clusters   
Loose 
clusters/syncitia/single 
Cells Enlarged, pleomorphic variable in number. 
Enlarged, relatively 
uniform, often 
numerous. 
Enlarged, pleomorphic. 
N/C ratio Normal/increased Increased(slight to moderate) 
Increased(moderate to 
marked) 
Nucleus Central Eccentric, enlarged. Eccentric, pleomorphic 
Nuclear 
membrane Smooth,thick. Slightly irregular, thin 
Moderate to markedly 
irregular. 
Chromatin Fine, even Granular, even Coarse, dark, irregular 
Nucleoli Often large Small to none Macronucleoli in many cells 
Cytoplasm Vacuolated Homogenous Often vacuolated also squamous 
Background Inflamed or clean Clean Diathesis 
 
High nuclear cytoplasmic ratio, irregular nuclear membrane, 
nonvacuolated cytoplasm are three key features in the diagnosis of low grade 
transitional cell carcinoma42. 
  
 
Dysplasia 
     Dysplasia describes a flat, non-invasive premalignant lesion distinguished 
from reactive or reparative epithelium.  The cytologic diagnosis of urothelial 
 dysplasia is a point of contention.  The cells are reported to have a lesser degree 
of cytologic atypia than transitional cell carcinoma in situ but are similar in 
appearance to cells from low-grade papillary neoplasms.  The chief differences 
are the small number of dysplastic cells present in urinary specimens, the 
aggregation of cells into small but loose clusters, a lower N/C ratio [Nuclear 
Cytoplasmic ratio] and fine evenly distributed chromatin.  In truth urothelial 
dysplasia cannot reliably be segregated from low-grade TCC with subjective 
criteria of cytology alone. 
Coy cells 
     These single small cells in the background have very high N/C ratio and 
abnormal slightly hyperchromatic nuclei with slightly coarse chromatin and 
irregular nuclear membranes.  These are the diagnostic cells to look for in low 
grade transitional cell carcinoma11. 
Papilloma  
Papillomas are well-differentiated papillary transitional cell neoplasms. 
Many papillomas are composed of cells with normal or nearly normal 
morphologic appearance, making cytologic diagnosis difficult or impossible. 
Others have morphologic feature of low-grade neoplasm.  Therefore only 1/3rd  
to 2/3rd of these lesions can be diagnosed cytollogically and the higher 
diagnostic yield (fewer false negatives) comes at the expense of more false-
positive diagnosis50. 
         Numerous cells may be exfoliated. Loose clusters and papillary 
 aggregates commonly occur, but must be differentiated from pseudopapillary 
clusters related to trauma instrumentation, stones, etc. True papillary fronds 
with fibrovascular cores are diagnostic of papillary neoplasia10. However, their 
presence is not essential for cytologic diagnosis. The cells and their nuclei are 
larger than normal deep transitional cells (but not superficial cells). The cell 
borders are often indistinct. The cytoplasm is homogeneous rather than 
vacuolated. The nuclei are eccentric and have slightly irregular membranes in 
the form of notches or creases. The chromatin is fine and evenly distributed. 
Nucleoli, if present, are small50,51. 
Carcinoma in Situ: 
 A lesion in which transitional epithelium, of variable thickness, is 
composed of variably sized abnormal cells with significant nuclear and 
cytoplasmic abnormalities, limited to the epithelium and never crosses the 
basal layer. 
Squamous Cell Carcinoma 
          Squamous cell carcinoma can be accurately identified from cells in urine 
sample.  They are usually well differentiated and exfoliate fairly mature cells 
with an elongated, spindled or fusiform configuration. Cytoplasmic 
keratinization can often be distinguished.  Nuclear border is irregular. Nuclear 
deformation is common. 
Adenocarcinoma 
         Primary adenocarcinomas are rare in the bladder.  The adenocarcinoma 
 cells tend to cluster and have poorly stained, lucent, vacuolated cytoplasm. 
Chromatin tends to aggregate along smooth nuclear borders and manifests. 
Nucleoli are prominent.  
Cystoscopy 
      Cystoscopy and cytology are complementary studies. The low-grade 
papillary lesions that may be difficult to diagnose cytologically are usually easy 
to diagnose cystoscopically. The papillae are almost literally waving at the 
observer through the cystoscope; however, lesions in the dome of the bladder or 
upper urinary tract may not be visualized21,37. Conversely, the high-grade flat 
carcinoma in situ or early invasive carcinoma, which is much more ominous, is 
easy to detect cytologically but may be missed cystoscopically even when 
extensive because it can be mistaken for hyperemia, cystitis, or even normal 
mucosa16,38. Furthermore cystoscopy is a burden for the patient and is not 
completely free of complication.   
 
Diagnostic correlation between cytologic and cystoscopic examination37. 
Cytology Cystoscopy Likely diagnosis 
(-) (-) No tumor. 
(-) (+) Well differentiated papillary neoplasm. 
(+) (-) Carcinoma in situ (or) upper tract tumor. 
(+) (+) High grade, invasive TCC 
        
      Transabdominal ultrasonography has also been used to complement urine 
cytology in the detection of bladder tumors. 
 Pitfalls in urinary cytology 
 Over interpreting cells with low N/C ratio [Nuclear Cytoplasmic ratio] as 
Cancer cells.  
 Mistaking papillary aggregates as a reliable sign of low grade neoplasia                
 Confusing the reactive/regenerative/reparative cell associated with urinary  
stones with neoplastic cells. 
 Over interpreting samples from the upper collecting system. 
 Misinterpreting cells in ileal conduits and  
 Misunderstanding the cytologic effects of drugs and X ray therapy.  
                                                                                                                                          
Morphologic features 
     TCC [Transitional Cell Carcinoma] can arise any where in the bladder. 
Common locations are:  
         Lateral walls 37% 
         Posterior wall 18% 
         Trigone 12% 
          Neck 11% 
          Ureteric orifices 10% 
          Dome 8% and 
          Anterior wall 4% 
 
  Pattern of growth may be exophytic or endophytic or a combination of both. 
Exophytic tumor may adopt a papillary configuration (with central   
fibrovascular core) or a solid appearance(nodular).  
     Exophytic tumor results in clusters of tumor cells in the lamina propia 
 which may be under diagnosed as Von Brunn’s nests or cystitis glandularis or 
cystica.  This is referred to as the nested variant of transitional cell carcinoma. 
     Stromal invasion by transitional cell carcinoma proceeds in two stages. 
Invasion of the lamina propria and invasion of muscle layer. Muscle invasion is 
of great consequence because of its influence on therapy and prognosis. Care 
should be exercised not to misinterpret the inconsistent but sometimes 
prominent fascicles of muscularis mucosa as belong to the muscularis propria.It 
is also important not to misinterpret the mature adipose tissue commonly 
present in the lamina propria or muscularis propria as perivascular soft tissue, 
in order to avoid a tumor adjacent to fat in a biopsy specimen being badly 
overstaged. 
The cyto architectural variations that may occur in transitional cell 
carcinomia are  
1. Foci of glandular metaplasia are common, usually in the form of intra-
cytoplasmic mucin containing vacuoles.  
2. Foci of squamous differentiation especially in high grade tumors may be 
seen. 
3. Clear cells may be prominent in transitional cell carcinomia and 
simulate adenocarcinoma. 
4. Micropapillary pattern may occur which resembles that of ovarian 
serous papillary carcinoma. 
5. Rare variant of TCC is characterized by a plasmacytoid appearance that 
 mimics myeloma.  
Bladder Biopsy 
Transurethral Resection 
      Before tumors are resected, their location, number and size should be 
noted.  Endoscopically visualised characterization with predictive value for 
disease progression include shape (papillary versus sessile and flat), size (less 
than 2 cm versus greater than 5 cm) and the presence of associated mucosal 
abnormalities. 
After careful inspection has been completed, multiple cold cup biopsies 
are done.  A typical biopsy specimen will provide the pathologist with an 
adequate sample of tumor, lamina propria and occasionally superficial muscle.  
The advantages of the cold cup biopsy is that the cellular architecture is 
undisturbed by cautery artifact. Biopsies are routinely obtained from the tumor, 
adjacent to the tumor, lateral to each ureteral orifice, the mid bladder base and 
the prostatic urethra. Biopsies should also be taken from areas adjacent to the 
tumor and from endoscopically normal sites, as such specimens have predictive 
value and therapeutic implication in the management of patients with bladder 
cancer. Cold cup biopsies of mossy granular areas of bladder mucosa may be 
more  important than those of the flat red lesions. 
Kenneth B. Cummings et al21 suggested hot loop resection of the tumor, 
after adequate biopsy mapping of bladder mucosa. He also insisted that the 
resection must include sufficient muscle to allow adequate pathologic staging. 
As an adjunct to hot loop resection, a cold up biopsy of the tumor edge or base 
 can provide muscle for pathologic staging while reducing charring artifact and 
the risk of bladder perforation. Video cystoscopy, combined with continuous-
flow resectoscope, will allow safe resection in almost all cases. 
Radical cystectomy 
     Radical cystectomy is done for muscle invasive cancer. From radical 
cystectomy specimen bits should be taken from,  
1. Tumor- at least three sections through bladder wall. 
2. Bladder neck- one section. 
3. Trigone- two sections. 
4. Anterior wall- two sections. 
5. Posterior wall- two sections. 
6. Dome- two sections. 
7. Any abnormal looking area in bladder mucosa if not included in previous 
sections. 
8. Ureteral orifices, include intramural portion 
9. Ureteral proximal margins 
10. In males;sections from prostate and seminal vesicles 
11. Other organs present 
12. Perivesical lymph nodes if any. 
 Grading and Staging                  
Grading of urothelial tumors.18 
WHO/ISUP Grades (World Health Organization/International Society of 
Urological Pathology). Adopted as WHO system in 2004. 
     Urothelial papilloma 
     Urothelial neoplasm of low malignant potential 
     Papillary Urothelilal Carcinoma, low grade 
     Papillary Urothelial Carcinoma, high grade. 
WHO Grades (1973) 
     Urothelial Papilloma 
     Urothelial neoplasm of low malignant potential 
     Papillary Urothelial Carcinoma,   Grade 1 
     Papillary Urothelial Carcinoma,   Grade 2 
     Papillary Urothelial Carcinoma,   Grade 3    
 
 Histologic feature used to classify Urothelial Papillary lesions according to 
the scheme proposed by the WHO/ISUP [The World Health Organization / 
International Society of Urological Pathology].19 
 
 Papilloma Papillary neoplasm 
of low malignant 
potential 
Low grade 
Papillary 
Carcinoma 
High grade 
Papillary 
Carcinoma 
Architecture     
Papillae Delicate Delicate, Occasionally fused. 
Fused, branching 
and delicate 
Fused, branching 
and delicate 
Organization 
of cells 
Identical to 
normal 
Polarity identical to 
normal; any 
thickness; cohesive 
Predominantly 
ordered, yet 
minimal crowding 
and minimal loss 
of polarity; any 
thickness; 
cohesive 
Predominantly 
disordered with 
frequent loss of 
polarity, any 
thickness; often 
discohesive. 
Cytology     
Nuclear size Identical to normal 
May be uniformly 
enlarged 
Enlarged with 
variation in size 
Enlarged with 
variation in size 
Nuclear 
shape  
Identical to 
normal 
Elongated, round-
oval, uniform.  
Round-oval; slight 
variation in shape 
and contour. 
Moderate-
marked 
Pleomorphism. 
Nuclear 
Chromatin Fine  Fine 
Mild variation 
within and 
between cells. 
Moderate-
marked variation 
both within and 
between cells 
with 
hyperchromasia. 
Nucleoli Absent Absent to inconspicuous 
Usually 
inconspicuous* 
Multiple 
Prominent 
nucleoli may be 
present 
Mitosos Absent Rare, basal Occasional, at any level 
Usually frequent 
at any level 
Umbrella 
cells 
Uniformly 
present Present Usually present May be absent 
 
*     If present, small and regular and not accompanied by other features of high 
grade  
     carcinoma.  
 
 
 
 
                                                                                                                                                      
 Pathologic T (Primary tumor) staging of bladder carcinoma18. 
 
                    AJCC/UICC                      Depth of invasion 
Non invasive, Papillary Ta 
Carcinoma in situ(Non invasive, flat) Tis 
Lamina Propria invasion T1 
Muscularis Propria invasion T2 
Microscopic extravesicle invasion T3a 
Grass apparent extravesicle invasion T3b 
Invades adjacent structures T4 
[AJCC/UICC, American Joint Commission on Cancer/Union International Contre le Cancer.] 
Local spread and metastasis 
     Bladder carcinom may extend into the ureters, neck of the bladder, urethra, 
prostatic ducts and seminal vesicle. 
     Lymphnode metastasis in the pelvic chains are found in 25% of invasive 
tumors. The most common sites of distant metastatis are the lungs, liver, bone 
and central  nervous system. 
Histochemical and Immunohistochemical features. 
     The co-ordinate expression of CK7 and CK20 is a feature of transitional cell 
carcinoma.CK20 positivity is common and strong in the high grade tumors. 
Thrombomodulin and Uroplakin III are two new useful markers for transitional 
cell carcinomia, but the former is not very specific and the later is only 
moderately sensitive. 
     Other markers commonly expressed by these tumors are CEA and cathepsin 
B (high grade tumors), CA19-9, CD15 (leu M1), survivin and androgen 
 receptors.  Deletion of ABO blood group antigen is a common finding in 
transitional cell carcinomas particularly in high grade tumors.   
Staining for the basal lamina component laminin has been advocated for 
the detection of early stromal invasion.  Tenascin an extra-cellular matrix 
protein is strongly expressed in invasive, high-grade carcinomas with abundant 
stroma and is thought to reflect both the severity of the inflammatory infiltrate 
and the extent of stromal remodeling. 
Treatment 
     Treatment depends on the grade, stage and whether the lesion is flat or 
papillary. For small localized papillary tumor of low grade, transurethral 
resection, followed with periodic cystoscopies and urine cytology for rest of 
their life for tumor recurrence. For multifocal disease in the immediate post 
operative period, topical chemotherapy is instilled in the bladder. It reduces 
recurrence. For patients who are at high risk of recurrence and/or progression, 
topical immunotherapy with BCG is given after the biopsy site is healed. 
Radical cystectomy is done for: 
1. Tumors invading the muscularis propria, 
 
2. CIS [Carcinoma In Situ] or high grade papillary cancer refractory to 
BCG [Bacillus Calmette - Guerin]  and 
3. CIS extending into the prostatic urethra and extending down the prostatic 
ducts beyond the reach of BCG.  
 Advanced bladder cancer is treated by chemotherapy.  
Prognosis 
     The prognosis depends on histological tumor type and grade, the depth of 
invasion, presence or absence of lymphatic or blood vessel invasion and spread 
to distant sites. The grade and stage of the tumor are important prognostic 
factors. As the transitional cell carcinoma is a multi focal disease, the status of 
the residual epithelium is critically important in prognostic assessment of 
urothelial tumors.  
 
 MATERIALS AND METHODS 
The present study was undertaken in the Institute of Pathology and 
Electron Microscopy, Madras Medical College and the Department of Urology, 
Govt. General Hospital, Chennai. 
Voided urine specimens were collected from 54 patients and 
subsequently bladder biopsy specimens were obtained from these patients and 
results were correlated.  
From August 2004 to Feb 2006 voided urine specimens were obtained 
from 52 men 2 women patients, who had symptoms suggestive of bladder 
tumor or were being followed after treatment of transitional cell carcinoma of 
the bladder. They were in the age group of 28 years-85years. 
     For cytological examination freshly voided urine was collected in clean 
container avoiding early morning urine.  In case of female patients care was 
taken to avoid vaginal contamination.  Urine examination was repeated thrice.  
For the purposes of this study, the higher degree of abnormality observed in the 
three specimens was recorded as the conclusive diagnosis. 
     Urine specimen was centrifuged 2500 rpm for 20 minutes.  The supernatant 
was poured into disinfectant. The cells in ‘cellbutton’ mixed with the remaining 
one or two drops of supernatant, remaining in the side of the tube by gently 
flicking the tube with a finger. 
     The resulting cell suspension was removed using a pipette.  A single small 
drop was placed towards one end of a clean, labeled glass slide.  It was spread 
 rapidly and the smears are fixed in 95% Isopropyl alcohol immediately. 
     The slides were fixed at least for a minimum of 20 minutes.  Fixed smears 
were stained by using H & E stain and papanicoloau stain. 
     After staining the slides were mounted using DPX [Distrene 
Dibutylphthalate Xlol]. 
For Histopathology 
     The material was obtained from TURBT Specimen, Cystoscopic biopsy 
specimen and Radical cystectomy specimen. 
     The samples received were fixed in 10% formation of quantity 20 times, the 
volume of the specimen.  Then processed in automated tissue processor with a 
conventional timing.  Then slides were stained using H &E [Haematoxylin and 
Eosin] stain. 
Papanicoloau staining 5 
Staining Technique 
1. Fix smears (while still moist) in equal parts of alcohol and ether for 15 - 
30 minutes. 
2. Rinse smears in distilled water. 
3. Stain in Harri’s Haematoxylin for 4 mts. 
4. Wash in tap water for1-2mts. 
5. Differentiate in acid alcohol. 
6. Blue in tap water or 1.5%sodium bicarbonate 
7. Rinse in distilled water. 
8. Transfer to70% then 95% alcohol for few seconds. 
 9. Stain in OG-6 for 1-2 mts 
10. Rinse in 3 changes of 95% alcohol for few seconds each. 
11. Stain in EA-36 for 1 - 2 mts 
12. Rinse in 3 changes of 95% alcohol for few seconds each 
13. Dehydrate in absolute alcohol, clear in xyol and mount in DPX.[Distrene 
Dibutylphthalate Xlol] 
Result 
     Nuclei - Blue 
     Acidophilic cells - Red to Orange 
     Barophilic cells - Green to blue green 
     Cells or fragments of tissue penetrated by blood- Orange to Orange Green.  
 
H & E staining [Heamatoxylin and Eosin] for tissue sections26  
Staining technique 
1. Dewax sections, hydrate, through graded alcohol to water 
2. Remove fixation pigments if necessary. 
3. Stain in alum hematoxylin of choice for a suitable time. 
4. Wash well in running tap water until sections ‘blue’ for 5 minutes or 
less. 
5. Differentiate in 1% acid alcohol (1% Hcl in 70% alcohol) for 5- 10 sec 
6. Wash well in tap water until sections are again blue (10 - 15 minutes) or 
7. Blue by dipping in an alkaline soluition (eg ammonia water) followed by 
a 5 min tap water wash. 
8. Stain in 1% eosin  for 10 minutes 
9. Wash in running tap water for 1 - 5 minutes 
 10. Dehydrate through alcohols, clear and mount. 
Results 
     Nuclei - blue/black 
     Cytoplasm - varying shades of pink 
     Muscle fibres - Deep pink/red 
     RBC[Red  blood Cells] -Orange/red 
     Fibrin - deep pink 
For heamatoxylin and eosin staining of cytology smears 0.5% acid alcohol is 
used 
 for differentiation 
Urine cytology smears were diagnosed as 
         Negative for malignancy 
         Atypical/reactive cells 
         Degenerated cells 
         Suspicious for malignancy. 
         Positive for Malignancy      
                   Low grade 
                   High grade 
For this purpose of study cytological negative, atypical/ reactive and 
degenerated smears are combined into one group i.e. cytologic negative. 
Suspicious and positive smears were combined into another group i.e. cytologic 
positive. 
Histopathology slides were diagnosed as 
     No malignancy 
     Low grade transitional cell carcinoma 
     High grade transitional cell carcinoma 
Then Cyto - Histological correlation was done. 
 Correlation was also done with cystoscopic findings and cytological, 
histopathalagical findings. Histological diagnosis was based on WHO grading 
     The tumors showing delicate orderly arranged papillary structures with 
minimal crowding, with enlarged cells, round to oval slightly variable sized 
nuclei, inconspicuous nucleoli and occasionally found mitosis were classified 
as low grade transitional cell carcinoma 
     The tumors showing disorderly arranged papillary structures with loss of 
polarity, enlarged cells with pleomorphic nuclei showing multiple prominent 
nucleoli and frequent mitosis were diagnosed as high grade transitional cell 
carcinoma.     
Criteria for cytological diagnosis 
Atypical/reactive cells 
 Enlarged cells with vacuolated cytoplasm and large centrally placed nuclei 
with smooth nuclear borders and multiple prominent nucleoli and fine even 
chromatin were diagnosed as atypical/reactive cells50,51  
Degenerated cells 
     Cells with disintegrated cytoplasm, smudged or degenerated chromatin and 
degenerated nuclei were diagnosed as degenerated cells37. 
Suspicious cells 
      The diagnosis of suspicious was rendered when the evidence was judged to 
be strongly suggestive of cancer but insufficient for an outright- diagnosis24. 
Low-grade transitional cell carcinoma                                                             
      Papillary or loose clusters of large cells with homogeneous cytoplasm and 
eccentricity placed enlarged nuclei with irregular nuclear borders, fine even 
chromatin were diagnosed as low grade transitional cell carcinoma50,51. 
  
 
Urine sediment smear showing degenerated cell groups showing vacuolated 
cytoplasm and degenerated nuclei. H&E stain 400X. 
 
 
 
 
 
Urine sediment smear of low grade TCC. Pap stain 400X. 
 
 
 
 
 
 
 
  
 
Urine sediment smear of low grade TCC H&E 400X 
 
 
 
Histology of low grade papillary TCC showing branching, delicate 
papillae. Scanner view 
 
 
  
 
 
Histology of low grade papillary TCC showing branching, delicate 
papillae with orderly arrangement of cells H & E 100X. 
 
 
 
 
 
 
Histology of low grade papillary TCC showing papillary structure with orderly 
arranged cells. The cells show mild nuclear size variation                          H & E 
400X. 
  
 
 
Urine sediment smear of high grade TCC showing large cells with pleomorphic 
hyperchromatic nuclei. H&E 400X. 
 
 
 
 
 
 
 
 
Urine sediment smear of high grade TCC showing large cells with pleomorphic 
hyperchromatic nuclei. H&E 400X. 
 
 
 
 
 
  
 
Histology of high grade papillary TCC H &E 100X. 
 
 
 
 
 
 
 
 
Histology of high grade papillary TCC showing cells with pleomorphic 
hyperchromatic nuclei H & E 400X 
 
 
 
 
 
 
  
 
Histology of high grade papillary TCC with squamous metaplasia  
H & E 100X. 
 
 
 
 
 
 
 
Histology of TCC with muscle invasion H & E  100X 
 
 
  
 
Histology of TCC with muscle invasion H & E  100X 
 
 
 
 
 
 
Histology of TCC with muscle invasion H& E 400X 
 
 
 
 High-grade transitional cell carcinoma 
      Loose clusters or isolated large cells with vacuolated cytoplasm, 
eccentricity placed pleomeorphic nuclei with increased N/C ratio [Nuclear 
Cytoplasmic ratio],  irregular nuclear borders, coarse uneven chromatin and 
multiple nucleoli were diagnosed as high grade transitional cell carcinoma50,51. 
      Cyto-hystological correlation was done patient based rather than specimen 
based.  Such that one patient with multiple specimens, correlation was 
tabulated only one time. 
     A positive correlation satisfied one of the two conditions.          
1. A patient with at least one positive urinary cytology concurrent with 
positive histological specimen or 
2. A patient with consistently negative urinary cytology and histology 
specimen. 
A discordant correlation was taken when at least one positive diagnosis by 
either cytology or histology and negative findings by the other modality.       
An explanation of discordant results was determined.  
 RESULTS AND OBSERVATION 
 
     A total of 54 cases were studied for cyto-histological correlation of bladder 
cancer. 
     Table 1 shows age/sex wise distribution of 54 cases 
TABLE 1: 
 
AGE[Years] MALE[Number] FEMALE[Number] 
20-29 2  
30-39 1  
40-49 7 1 
50-59 19 1 
60-69 18  
70-79 4  
80-89 1  
TOTAL 52 2 
 
  
Among 54 cases, histologically proven bladder tumor cases were 45.  Table 2 
shows age/sex wise distribution of histologically proven cases. 
 
TABLE 2 
 
 
AGE[Years] MALE[Number] FEMALE[Number] 
20-29 2  
30-39 1  
40-49 7 1 
50-59 15  
60-69 14  
70-79 4  
80-89 1  
TOTAL 44 1 
 
 Among 54 cases, nine cases showed histologically negative results. 
Table 3 shows cytological and cystoscopic findings in histologically negative 
cases. 
TABLE 3 
 
CASE 
NUMBER HISTOLOGY CYTOLOGY CYSTOSCOPY 
3 Negative Negative Thickening  of bladder wall seen 
21 Negative Negative ? Growth right lateral wall of bladder. 
22 Negative. Negative Growth right lateral wall 
24 Negative Positive No growth 
28 Negative Negative Bulging seen in the right lateral wall. 
36 Negative Positive No growth 
38 Negative Positive No growth 
40 Negative Positive No growth 
50 Negative Negative Thickened bladder wall seen 
 
  
Histologic diagnosis and cytological findings of 54 cases was shown in table 4. 
 
TABLE 4: 
 
                 CYTOLOGY 
HISTOLOGY 
POSITIVE NEGATIVE 
TOTAL 
LOW  GRADE 11 10 21 
HIGH GRADE 19 5 24 
NEGATIVE 4 5 9 
TOTAL 34 20 54 
 
 
 
 
Cyto-Histological grading of urothelial neoplasm was shown in TABLE 5 
TABLE 5: 
 
CYTOLOGY 
HISTOLOGY NUMBER OF CASES LOW-GRADE HIGH-GRADE 
LOW-GRADE 11 10 1 
HIGH-GRADE 19 3 16 
 
 Cyto-Histological correlation for patients with bladder cancer shown in 
TABLE 6. 
TABLE 6 : 
CYTOLOGY HISTOLOGICAL 
GRADE 
TOTAL 
NUMBER 
OF CASES POSITIVE NEGATIVE 
% OF 
POSITIVE 
LOW GRADE 21 11 10 52.38 
HIGH GRADE 24 19 5 79.16 
  
 
 
False positive findings on cytologic examination with clinical findings shown 
in 
TABLE 7.                                                                                                                                      
TABLE 7: 
CASE 
NUMBER 
CYTOLOGY CLINICAL FINDINGS 
24 Positive-High grade Cystoscopy negative. Biopsy negative. 
36 Positive -High grade Cystoscopy negative. Biopsy negative. History of radiation present. 
38 Positive-High grade Cystoscopy negative. Biopsy negative 
40 Positive-High grade Cystoscopy negative.Biopy negative.History of radiation present. 
  
 Overall, Cyto-Histological correlation was 65% 
65%
35%
Postive Correlation Negative Correlation
 
52% of the low-grade tumors were detected by cytology. 
52%
48%
Low Grade TCC Detected by Cytology
Low Grade TCC Not Detected by Cytology
 
 79% of the high-grade tumors were detected by cytology 
79%
21%
High Grade TCC Detected by Cytology
High Grade TCC Not Detected by Cytology
 
Among the 54 cases  
True positives [TP] were 30 
False positives [FP] were 4 
False  negatives [FN] were 15 
True negatives[TN] were 5 
TABLE  8 shows these details. 
TABLE 8 
 BIOPSY 
CYTOLOGY POSITIVE NEGATIVE 
TOTAL 
POSITIVE 30[TP] 4[FP] 34 
NEGATIVE 15[FN] 5[TN] 20 
TOTAL 45 9 54 
Specificity of urine cytology= TN/TN+FP=56% 
Sensitivity of urine cytology=TP/TP+FN=67% 
The results showed more number of bladder cancer cases in the age group of 50 
- 69 years with male preponderance. 
      Among the 54 cases 45 were confirmed histologically, which includes 21 
cases of low grade transitional cell carcinoma and 24 cases of high grade 
transitional cell carcinoma. 
     Among the 54 cases 9 were histologically negative. 
      28 out of 45 cases of transitional cell carcinoma were correctly identified 
by cytological examination. 
     2 cases showed suspicious cytology. 
     15 cases produced negative cytological findings. 
     Among the cytologically negative 15 cases, 10 were diagnosed as low grade 
tumors in histology and 5 were diagnosed as high grade TCC [Transitional cell 
carcinoma] in histology. 
     There were 4 false positives. (Table 7) 
     A summary of the cyto-histological grading results are shown in table 5.  
High grade TCC  had high correlation whereas low grade TCC  had a poor 
correlation. 
     Histologically confirmed high grade TCC occurred in 24 patients of whom 
19 were detected cytologically i.e. 79% were detected by cytology. 
     Histologically confirmed low grade TCC occurred in 21 patients of whom 
11 were detected cytologically i.e. 52% were detected by cytology. 
     Histologically confirmed TCC occurred in 45 patients of whom 30 patients 
were diagnosed cytologically i.e. 67% were detected by cytology.   
 
 Assessment of false positive cases: 
     Table 7 shows false positive cases i.e. positive cytology and negative 
histopathology diagnosis. 
     4 cases showed false positive cytological findings. 
     2 out of 4 cases received radiotherapy in the past and the radiation induced 
changes were falsely diagnosed as high grade TCC.  In 2 cases, the cytology 
was positive and cystoscopy showed no growth. Random biopsy was negative 
for transitional cell carcinoma. Thereafter these two patients could not be 
followed up. 
Assessment of false negative cases: 
     15 cases showed false negative cytology i.e. cytology negative and 
histology positive. 
     Among the 15 cases 10 cases were diagnosed as low grade tumor by 
histology and 5 were diagnosed as high grade tumor by histology. 
     Among the 10 low grade tumors, which were cytologically negative, 4 
showed atypical and degenerative changes and 6 showed only normal urothelial 
cells. 
 
 
 
 
  
 
Urine sediment smear; catheter artifact- showing papillary clusters of 
cells with smooth outline H&E stain 400X. 
 
      Among the 5 high grade tumors, which were cytologically negative, 3 
showed atypical changes. Among these 3 which showed atypical changes, 2 
showed abundant background acute inflammatory cell collection. 
     During our study we came across one urinary specimen smear which 
showed papillary  clusters with smooth borders; it was due to previous 
catheterization. 
 DISCUSSION 
 
     A cytological examination of voided urine is the only non invasive and 
totally harmless method of detection, diagnosis and follow up of tumors of the 
lower urinary tract. Bladder washing or barbotage is an invasive procedure. In 
our study voided urine samples from the patients were used for cytological 
examination. 
     The value of repeated cytological examination of urine for 3 consecutive 
days was reported by Leopold G. Koss et al 198524.  In the present study also 
urine was examined on 3 consecutive days. 
     The average patient is 65 to 70 years old and most patient are older than 50 
years In our study maximum number of cases (29) occurred in the age group of 
50 - 69 years and total number of patients over 50 years of age was 34. 
     Consistent with previously published data13,14,24,44 in the literature, this study 
also showed higher diagnostic accuracy with high grade tumors and low with 
low grade tumors. In our study 79% high grade tumors were detected by 
cytology but only 52% of the low grade tumors were detected by cytology. 
     Cigarette smoking is a risk factor for bladder cancer. In our study, of the 45 
 biopsy proven bladder cancer cases, 36 cases occurred in smokers. 
     Eighty percent of the patients with bladder carcinoma present with gross or 
microscopic hematuria21. In our study hematuria is a presenting symptom in 38 
out of 45 biopsy proven bladder cancer patients. 
     Cystoscopy and cytology are complementary studies. The low grade 
papillary 
 lesions that may be difficult to diagnose cytologically are usually easy to 
diagnose 
cystoscopically.In our study out of 10 cases which were falsely diagnosed as 
negative in cytological examination 8 showed cystoscopically diagnosable 
growth. 
     The sensitivity and specificity of the voided urine cytology in the studies 
conducted by various authors. 
S.NO Author Sensitivity Specificity 
1. M.N.EL-Bolkainy30 1980      44.7 to 97.3%        
with mean of 
73.8%  
88% to 99.5% with 
mean of 97.1% 
2. Uma A. Shenoy et al44 
1985                        
85% 99% 
3. Asitava Mondal et al4 1992 92% 88% 
4. Misra V et al28 2000              47.37% 41.18% 
5. V. Poulakis et al46 2001 62% 96% 
6. A. Saad  et al3 2002 48% 87% 
7. Planz B et al35 2005 38% 98.3% 
 
    Our study showed a sensitivity of 67% and specificity of 56% for urine 
cytology. 
     The study conducted by William M. Murphy et al50 1984-showed overall 
cyto-histological correlation of 92% 
     The study conducted by Uma A. Shenoy et al44 1985-showed overall cyto-
histological correlation of 74% 
     In the study conducted by DiBonito L et al7 1992 cyto-histological 
correlation varied from 20% to 92.8%. 
     In our study the overall cyto-histological correlation was 65%. 
 
 False positive cases: 
     Radiation can cause cellular changes like multinucleation, nuclear 
enlargement, cytoplasmic vacuolation, Karyorrhexis.  
     The study conducted by P. N. Cowen36 showed that it is impossible to state 
with any degree of certainty whether any atypical or bizarre cells seen in urine 
indicate a neoplastic origin or whether they are due to the irradiation of non-
neoplastic epithelial cells. 
     Our study also showed similar findings. In two cases, who previously 
received radiation, the urine cytology showed bizarre cells which were 
diagnosed falsely as high grade TCC [Transitional cell carcinoma]. 
     So it is essential that the cytologists be informed whether (and when) 
previous radiotherapy has been given to the patient as insisted by P. 
N.Cowen36. 
     In 2 cases, the cytology was positive and cystoscopy showed no growth. 
Random biopsy was negative for transitional cell carcinoma. Thereafter these 2 
Patients could not be followed up. In-adequate follow-up may be the cause for 
false-positivity.  
     According to David M. Schwalb et al6, inadequate follow up may be the 
cause of false-positivity, he also said that a positive and even suspicious result 
in the absence of visible disease in the previously untreated patient predicts the 
eventual development of clinically recognizable transitional cell carcinoma, 
mainly in the bladder.                    
 False positive rates reported by various authors: 
        The study conducted by M.N.EL-Bolkainy30 showed false positive rate of 
1.5%. The study conducted by Uma A. Shenoy et al44 showed false positive 
rate of 11%. According to Edward M. Messing8 it was 1-12%. 
     In our study it is 12%, it also correlates well with other authors’ study. 
     False positive cytological findings may develop a tumor in subsequent years 
and therefore needs repeated examination of urine for malignant cells4,31,44. 
False negative cases: 
     Among the 45 biopsy proven bladder neoplastic cases 15 were falsely 
diagnosed as negative cytologically.  Among the15 cases 10 were low grade 
tumor and 5 were high grade tumors. 
     Among the 10 low grade tumors, which were cytologically negative 6 
showed only normal urothelial cells and 4 showed atypical and degenerative 
changes. This may be  due to exfoliation of non-diagnostic cells from low 
grade tumors. 
     Among the 5 high grade tumors which were cytologically negative, 3 
showed atypical cellular changes. Among the 3, two showed heavy background 
inflammatory cell collection. 2 out of 5 high grade tumors didn’t show any 
malignant cells in cytology. This may be due to masking of the tumor cells by 
associated inflammation or hemorrhage, and scanty exfoliation of necrotic 
tumors as stated by M.N.EL-Bolkainy30. 
     Three case of histologically proven high grade tumors were detected as low 
 grade tumors by cytology and one case of histological low grade tumor was 
cytologically diagnosed as high grade tumor, a more likely explanation is that 
the bladder cancers are rarely composed of a pure population of cells, all of 
which are in the same stage of differentiation at any one point in time. High 
grade TCC may exhibit surface maturation, and tumor cells exfoliated from 
these areas could have a cytological features of a low-grade neoplasm, less 
commonly small areas of anaplasia may exist within predominantly low grade 
tumors. 
  
 
LIMITATIONS 
 
 As the sample population is small the sensitivity and specificity of this 
study may not be so accurate. 
 
 Even though urinary telomerase activity is the most sensitive and specific 
test to detect bladder tumors we have not done it because of its cost. 
 
 As the study is time bound we are not able to detect the time interval 
between primary diagnosis and recurrence.  
 SUMMARY 
 More than 50% (64.44 %) of cases occurred in the age group of 50 -
69  years with male preponderance 
 More than 50% (67%) of the bladder cancers can be detected by 
simple, non-invasive, voided urine cytology. 
 Nearly 80% (79%) of the high grade bladder cancers can be detected 
by voided urine cytology. 
 But only nearly 50% (52%) of the low grade bladder cancers can be 
detected by voided urine cytology. 
 More than 50% (65%) of the cytological diagnosis were correlated 
well with histopathological diagnosis. 
 Inadequate follow up and previous therapy led to false positive 
diagnosis. 
 Cystoscopy is more useful in low grade tumors which were 
diagnosed falsely as negative by cytology. 
 
 
 
 
 
 
 CONCLUSION 
 
 Cytological examination of urine specimen is valuable as an aid in the 
diagnosis and follow up study of bladder tumors. 
 The voided urine cytology is not only of diagnostic but also of 
prognostic value; positive cytology presumably identifies patients at 
high risk. 
 The accuracy is more with high grade tumors. 
 Voided urine cytology correlates well with histological diagnosis in 
more than 50% cases 
 Previous therapy reduces the diagnostic accuracy of voided urine 
cytology. 
 Cystoscopy may be of more useful in diagnosing low grade tumors 
which were missed by voided urine cytology. 
 Voided urine cytological study can be a most valuable adjunct to the 
clinician in the evaluation of urologic patient as it is simple, non-
invasive with good accuracy in the diagnosis.   
 
 Master Chart 
Cytological Diagnosis Histopathological Diagnosis 
Positive Positive 
Grade Grade 
Case 
No Name Age/Sex IP.No C.No 
Low High 
Negative Suspicious B.No 
Low High 
Negative 
1 Mr. Mohan 26/M 684210/04 5109/04   *  5761/04 *   
2 Mr. Kamaraj 46/M 685552/04 5341/04  *   6424/04  *  
3. Mr. Murugan 55/M 684773/04 5407/04   *  6152/04   * 
4. Mr.Sambath 45/M 684745/04 5408/04    * 6060/04 *   
5. Mr.Murugayan 57/M 685395/04 5492/04  *   6151/04  *  
6. Mr Duraikannan 65/M 689193/04 6042/04   *  6693/04 *   
7. Mr.Durai. 50/M 696753/04 6571/04  *   7282/04  *  
8. Mr. Sadagopan 69/M 700618/05 1/05   *  186/05  *  
9 Mr. Varadhan 72/M 704264/05 471/05 *    482/05 *   
10. Mr.Thanikachalam 50/M 707349/05 834/05  *   955/05  *  
11. Mr.AdiNarayanan 46/M 708362/05 929/05  *   934/05  *  
12. Mr.Sethan 61/M 708453/05 946/05 *    1014/05 *   
13. Mr. Lingam 55/M 709585/05 1024/05  *   961/05  *  
14. Mr.Duraiswamy 44/M 710411/05 1142/05    * 1128/05 *   
15 Mr.SathyaNarayanan. 65/M 704270/05 1226/05   *  1035/05 *   
16 Mr.Krishnan 63/M 710102/05 1376/05   *  933/05  *  
17 Mr.Kasi 60/M 712379/05 1411/05 *    2080/05  *  
18 Mr.Kalyani 50/M 712348/05 1412/05 *    1671/05  *  
19 Mr. Madhar 45/M 713183/05 1421/05   *  1558/05  *  
20 Mr Arumugam 47/M 710084/05 1438/05  *   1327/05 *   
21 Mrs. Saroja 50/F 714274/05 1506/05   *  1223/05   * 
22 Mr.Bhatacharji 68/M 714423/05 1629/05   *  1490/05   * 
23 Mr.Mani 70/M 716892/05 1883/05  *   1602/05  *  
24 Mr. Kaveri 68/M 716878/05 1895/05  *   1815/05   * 
25 Mr. Kannan 60/M 717720/05 2038/05  *   1763/05  *  
26 Mr.Sengai. 59/M 715917/05 2976/05   *  1628/05 *   
27 Mr.Thangavel 65/M 718966/05 2165/05   *  1963/05  *  
28 Mr. NavajNivas 59/M 720086/05 2166/05   *  1967/05   * 
 29 Mr. Kadupadi 52/M 720549/05 2406/05  *   2101/05  *  
30 Mr. Santhanam 64/M 724401/05 3044/05  *   2723/05  *  
 
Cytological Diagnosis Histopathological Diagnosis 
Positive Positive 
Grade Grade 
Case 
No Name Age/Sex IP.No C.No 
Low High 
Negative Suspicious B.No 
Low High 
Negative 
31 Mr. Venkatamuni 65/M 726712/05 3099/05  *   2719/05  *  
32 Mr. Chinnakannu 55/M 724603/05 3128/05  *   2741/05  *  
33 Mr. Gandhimathinathan 49/M 639747/05 3944/05 *    2989/05 *   
34 Mr. Kaliappan 65/M 732583/05 4061/05 *    4129/05 *   
35 Mr.Balakrishnan 54/M 734048/05 4064/05  *   3619/05  *  
36 Mr. Elumalai. 51/M 750184/05 4075/05  *   5041/05   * 
37 Mr. Sundaram. 65/M 753638/05 4083/05   *  5140/05 *   
38 Mr. Devarajan 55/M 733837/05 4085/05  *   5970/05   * 
39 Mr. Venugopal 85/M 734863/05 4195/05  *   3620/05  *  
40 Mr. Ramachandran 60/M 736076/05 4199/05  *   3914/05   * 
41 Mr. Kuppan. 65/M 737702/05 4440/05   *  4206/05 *   
42 Mr. Subramani 28/M 743201/05 4717/05   *  3802/05 *   
43 Mr. Periyasamy 50/M 743538/05 4985/05 *    4727/05 *   
44 Mr. Velu 60/M 745407/05 5185/05 *    4542/05 *   
45 Mr. Veeraswamy 58/M 745207/05 5251/05 *    4436/05 *   
46 Mrs.sarojini 40/F 752349/05 5973/05  *   5068/05  *  
47 Mr. Durairajan 51/M 753042/05 6212/05 *    5454/05 *   
48 Mr.Muthu 70/M 754780/05 6331/05   *  5479/05 *   
49 Mr. Kadharbasha 52/M 755680/05 6469/05   *  5481/05  *  
50 Mr. Govindaswamy 52/M 765278/05 6853/05   *  6088/05   * 
51 Mr. Natarajan 69/M 764855/05 7397/05  *   6254/05  *  
52 Mr. Babu 50/M 770398/05 8000/05   *  6748/05 *   
53 Mr.Muthunadar 70/M 773171/05 8336/05   *  290/06  *  
54 Mr. Ganesan 36/M 782218/06 738/06   *  777/06 *   
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